CD4 antibody therapy and cyclosporin A differentially affect HLA-DR and ICAM-1 expression in psoriatic skin.
J F
JF
Nicolas
H
H
Rizova
A
A
Demidem
J
J
Thivolet
P
P
Morel
J P
JP
Revillard
D000906:Antibodies / Q000276:immunology / Q000627:therapeutic use*; D015704:CD4 Antigens / Q000276:immunology*; D015815:Cell Adhesion Molecules / Q000096:biosynthesis*; D016572:Cyclosporine / Q000627:therapeutic use*; D006684:HLA-DR Antigens / Q000096:biosynthesis*; D006801:Humans; D007167:Immunotherapy; D018799:Intercellular Adhesion Molecule-1; D011565:Psoriasis / Q000276:immunology / Q000628:therapy*; D012867:Skin / Q000187:drug effects / Q000276:immunology*
D000906:Antibodies; D015704:CD4 Antigens; D015815:Cell Adhesion Molecules; D006684:HLA-DR Antigens; D018799:Intercellular Adhesion Molecule-1; D016572:Cyclosporine